Plasmacytoid dendritic cells license regulatory T cells, upon iNKT-cell stimulation, to prevent autoimmune diabetes

European Journal of Immunology

Volumn 44, Issue 5, 2014, Pages 1454-1466

  Beaudoin, Lucie ^a,b   Diana, Julien ^a,b   Ghazarian, Liana ^a,b   Simoni, Yannick ^a,b   Boitard, Christian ^a,b   Lehuen, Agnès ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Diabetes; NKT; NOD; Plasmacytoid dendritic cells; Regulatory T (Treg) cells

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD103 ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; PROINSULIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DIABETOGENESIS; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INVARIANT NATURAL KILLER T CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE MIGRATION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PANCREAS ISLET; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

DIABETES; NKT; NOD; PLASMACYTOID DENDRITIC CELLS; REGULATORY T (TREG) CELLS;

ANIMALS; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; ISLETS OF LANGERHANS; LYMPH NODES; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; PLASMA CELLS; PROINSULIN; T-LYMPHOCYTES, REGULATORY;

EID: 84899494386     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343910     Document Type: Article

References (47)

1. Lehuen, A., Diana, J., Zaccone, P. and Cooke, A., Immune cell crosstalk in type 1 diabetes. Nat. Rev. Immunol. 2010. 10: 501-513.
2. Diana, J., Simoni, Y., Furio, L., Beaudoin, L., Agerberth, B., Barrat, F. and Lehuen, A., Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat. Med. 2013. 19: 65-73.
3. Husebye, E. S. and Anderson, M. S., Autoimmune polyendocrine syndromes: clues to type 1 diabetes pathogenesis. Immunity 2010. 32: 479-487.
4. 3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 2008. 9: 239-244.
5. Simoni, Y., Diana, J., Ghazarian, L., Beaudoin, L. and Lehuen, A., Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality? Clin. Exp. Immunol. 2013. 171: 8-19.
6. Diana, J. and Lehuen, A., NKT cells: friend or foe during viral infections? Eur. J. Immunol. 2009. 39: 3283-3291.
7. Diana, J., Brezar, V., Beaudoin, L., Dalod, M., Mellor, A., Tafuri, A., von Herrath, M. et al., Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay. J. Exp. Med. 2011. 208: 729-745.
8. Hammond, K. J., Poulton, L. D., Palmisano, L. J., Silveira, P. A., Godfrey, D. I. and Baxter, A. G., Alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med. 1998. 187: 1047-1056.
9. Lehuen, A., Lantz, O., Beaudoin, L., Laloux, V., Carnaud, C., Bendelac, A., Bach, J. F. et al., Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 1998. 188: 1831-1839.
10. Sharif, S., Arreaza, G. A., Zucker, P., Mi, Q. S., Sondhi, J., Naidenko, O. V., Kronenberg, M. et al., Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat. Med. 2001. 7: 1057-1062.
11. Mizuno, M., Masumura, M., Tomi, C., Chiba, A., Oki, S., Yamamura, T. and Miyake, S., Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice. J. Autoimmun. 2004. 23: 293-300.
12. Ly, D., Tohn, R., Rubin, B., Blumenfeld, H., Besra, G. S., Veerapen, N., Porcelli, S. A. et al., An alpha-galactosylceramide C20:2 N-acyl variant enhances anti-inflammatory and regulatory T cell-independent responses that prevent type 1 diabetes. Clin. Exp. Immunol. 2010. 160: 185-198.
13. Hong, S., Wilson, M. T., Serizawa, I., Wu, L., Singh, N., Naidenko, O. V., Miura, T. et al., The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 2001. 7: 1052-1056.
14. Laloux, V., Beaudoin, L., Jeske, D., Carnaud, C. and Lehuen, A., NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen. J. Immunol. 2001. 166: 3749-3756.
15. Beaudoin, L., Laloux, V., Novak, J., Lucas, B. and Lehuen, A., NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells. Immunity 2002. 17: 725-736.
16. Chen, Y. G., Choisy-Rossi, C. M., Holl, T. M., Chapman, H. D., Besra, G. S., Porcelli, S. A., Shaffer, D. J. et al., Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes. J. Immunol. 2005. 174: 1196-1204.
17. Naumov, Y. N., Bahjat, K. S., Gausling, R., Abraham, R., Exley, M. A., Koezuka, Y., Balk, S. B. et al., Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc. Natl. Acad. Sci. USA 2001. 98: 13838-13843.
18. Wang, J., Cho, S., Ueno, A., Cheng, L., Xu, B. Y., Desrosiers, M. D., Shi, Y. et al., Ligand-dependent induction of noninflammatory dendritic cells by anergic invariant NKT cells minimizes autoimmune inflammation. J. Immunol. 2008. 181: 2438-2445.
19. Ly, D., Mi, Q. S., Hussain, S. and Delovitch, T. L., Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells. J. Immunol. 2006. 177: 3695-3704.
20. Thebault-Baumont, K., Dubois-Laforgue, D., Krief, P., Briand, J. P., Halbout, P., Vallon-Geoffroy, K., Morin, J. et al., Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice. J. Clin. Invest. 2003. 111: 851-857.
21. Simoni, Y., Gautron, A. S., Beaudoin, L., Bui, L. C., Michel, M. L., Coumoul, X., Eberl, G. et al., NOD mice contain an elevated frequency of iNKT17 cells that exacerbate diabetes. Eur. J. Immunol. 2011. 41: 3574-3585.
22. Ochando, J. C., Homma, C., Yang, Y., Hidalgo, A., Garin, A., Tacke, F., Angeli, V. et al., Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat. Immunol. 2006. 7: 652-662.
23. Sharma, M. D., Baban, B., Chandler, P., Hou, D. Y., Singh, N., Yagita, H., Azuma, M. et al., Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2, 3-dioxygenase. J. Clin. Invest. 2007. 117: 2570-2582.
24. Hadeiba, H., Sato, T., Habtezion, A., Oderup, C., Pan, J. and Butcher, E. C., CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat. Immunol. 2008. 9: 1253-1260.
25. Frigerio, S., Junt, T., Lu, B., Gerard, C., Zumsteg, U., Hollander, G. A. and Piali, L., Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat. Med. 2002. 8: 1414-1420.
26. Yamada, Y., Okubo, Y., Shimada, A., Oikawa, Y., Yamada, S., Narumi, S., Matsushima, K. et al., Acceleration of diabetes development in CXC chemokine receptor 3 (CXCR3)-deficient NOD mice. Diabetologia 2012. 55: 2238-2245.
27. Wilson, S. B., Kent, S. C., Patton, K. T., Orban, T., Jackson, R. A., Exley, M., Porcelli, S. et al., Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 1998. 391: 177-181.
28. Carnaud, C., Gombert, J., Donnars, O., Garchon, H. and Herbelin, A., Protection against diabetes and improved NK/NKT cell performance in NOD.NK1.1 mice congenic at the NK complex. J. Immunol. 2001. 166: 2404-2411.
29. Poulton, L. D., Smyth, M. J., Hawke, C. G., Silveira, P., Shepherd, D., Naidenko, O. V., Godfrey, D. I. et al., Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Int. Immunol. 2001. 13: 887-896.
30. Kent, S. C., Chen, Y., Clemmings, S. M., Viglietta, V., Kenyon, N. S., Ricordi, C., Hering, B. et al., Loss of IL-4 secretion from human type 1a diabetic pancreatic draining lymph node NKT cells. J. Immunol. 2005. 175: 4458-4464.
31. Forestier, C., Takaki, T., Molano, A., Im, J. S., Baine, I., Jerud, E. S., Illarionov, P. et al., Improved outcomes in NOD mice treated with a novel Th2 cytokine-biasing NKT cell activator. J. Immunol. 2007. 178: 1415-1425.
32. Gomez-Diaz, R. A., Aguilar, M. V., Meguro, E. N., Marquez, R. H., Magana, E. G., Martinez-Garcia, M. C., Rodarte, N. W. et al., The role of natural killer T (NKT) cells in the pathogenesis of type 1 diabetes. Curr. Diabetes Rev. 2011. 7: 278-283.
33. Pennline, K. J., Roque-Gaffney, E. and Monahan, M., Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol. 1994. 71: 169-175.
34. Rapoport, M. J., Jaramillo, A., Zipris, D., Lazarus, A. H., Serreze, D. V., Leiter, E. H., Cyopick, P. et al., Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 1993. 178: 87-99.
35. Mi, Q. S., Ly, D., Zucker, P., McGarry, M. and Delovitch, T. L., Interleukin-4 but not interleukin-10 protects against spontaneous and recurrent type 1 diabetes by activated CD1d-restricted invariant natural killer T-cells. Diabetes 2004. 53: 1303-1310.
36. Wilson, S. B., Kent, S. C., Horton, H. F., Hill, A. A., Bollyky, P. L., Hafler, D. A., Strominger, J. L. et al., Multiple differences in gene expression in regulatory Valpha 24Jalpha Q T cells from identical twins discordant for type I diabetes. Proc. Natl. Acad. Sci. USA 2000. 97: 7411-7416.
37. Novak, J., Beaudoin, L., Griseri, T. and Lehuen, A., Inhibition of T cell differentiation into effectors by NKT cells requires cell contacts. J. Immunol. 2005. 174: 1954-1961.
38. Novak, J., Beaudoin, L., Park, S., Griseri, T., Teyton, L., Bendelac, A. and Lehuen, A., Prevention of type 1 diabetes by invariant NKT cells is independent of peripheral CD1d expression. J. Immunol. 2007. 178: 1332-1340.
39. Saraiva, M. and O'Garra, A., The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 2010. 10: 170-181.
40. Steinman, R. M., The control of immunity and tolerance by dendritic cell. Pathol. Biol. 2003. 51: 59-60.
41. Tang, Q. and Bluestone, J. A., Regulatory T-cell physiology and application to treat autoimmunity. Immunol. Rev. 2006. 212: 217-237.
42. Saxena, V., Ondr, J. K., Magnusen, A. F., Munn, D. H. and Katz, J. D., The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse. J. Immunol. 2007. 179: 5041-5053.
43. Martin-Gayo, E., Sierra-Filardi, E., Corbi, A. L. and Toribio, M. L., Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development. Blood. 2010. 115: 5366-5375.
44. Ito, T., Yang, M., Wang, Y. H., Lande, R., Gregorio, J., Perng, O. A., Qin, X. F. et al., Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J. Exp. Med. 2007. 204: 105-115.
45. Driver, J. P., Scheuplein, F., Chen, Y. G., Grier, A. E., Wilson, S. B. and Serreze, D. V., Invariant natural killer T-cell control of type 1 diabetes: a dendritic cell genetic decision of a silver bullet or Russian roulette. Diabetes 2010. 59: 423-432.
46. Lee, P. T., Putnam, A., Benlagha, K., Teyton, L., Gottlieb, P. A. and Bendelac, A., Testing the NKT cell hypothesis of human IDDM pathogenesis. J. Clin. Invest. 2002. 110: 793-800.
47. Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G. and Rudensky, A. Y., Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005. 22: 329-341.